Symmetry Investments’s Curis CRIS Stock Holding History

Symmetry Investments’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-47	Closed	-$90K	–	118
2021 Q4	$90K	Buy	+47	New	+$112K	0.03%	90

Other funds holding CRIS

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Symmetry Investments's CRIS Position: Q1 2022 in Review

Symmetry Investments sold out of Curis (CRIS) in Q1 2022, closing a stake of 47 shares — an estimated $90K sold.

Symmetry Investments first reported a position in CRIS in Q4 2021 and held it in 1 quarter. The position peaked at $90K in Q4 2021. 124 funds tracked by Wall St. Rank hold CRIS as of Q1 2022.

Symmetry Investments reported no remaining Curis position as of Q1 2022 after selling out during the quarter.
Symmetry Investments sold 47 Curis shares in Q1 2022, an estimated $90K.
Symmetry Investments first reported a position in Curis in Q4 2021 and held it in 1 quarter.
Symmetry Investments's Curis position peaked at $90K in Q4 2021.
124 funds tracked by Wall St. Rank held Curis as of Q1 2022.

Based on Symmetry Investments's 13F filing for Q1 2022, filed 13 May 2022.